NEW YORK (Reuters Health) – Whether delivery is immediate of deferred when fetal health is compromised by growth restriction appears to make no difference to outcomes at school…
NEW YORK (Reuters Health) – The benefits of cardiac resynchronization therapy (CRT) are less pronounced for typical “real-world” patients — particularly those with right bundle-branch block — than…
NEW YORK (Reuters Health) – Cure rates are similar when patients hospitalized with community-acquired pneumonia are treated with ceftaroline or ceftriaxone — but ceftaroline may have the edge,…
NEW YORK (Reuters Health) – Magnetic resonance imaging of ovarian tumors is useful in predicting whether the lesion is malignant or benign, thereby helping to guide the therapeutic…
NEW YORK (Reuters Health) – Outcomes of cryoablation of small renal masses are similar whether the procedure is performed surgically or percutaneously, according the results of a meta-analysis…
NEW YORK (Reuters Health) – The likelihood that a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive breast cancer on final…
NEW YORK (Reuters Health) – In terms of overall survival, carboplatin plus the oral fluoropyrimidine derivative S-1 is as effective as carboplatin plus paclitaxel in chemotherapy-naive patients with…
NEW YORK (Reuters Health) – Patients with papillary thyroid cancer who undergo lobectomy do as well as those who undergo total thyroidectomy, while external beam radiation is associated…
NEW YORK (Reuters Health) – The risk of second primary neoplasms (SPNs) of the central nervous system in survivors of childhood cancer increases greatly with the dose of…
NEW YORK (Reuters Health) – The off-label use of recombinant factor VIIa for hemostasis in patients without hemophilia confers only modest benefits but may increase the risk of…
NEW YORK (Reuters Health) – Family history, age, cholesterol and blood pressure levels, and conditions such as diabetes remain the mainstay of assessing the risk of cardiovascular disease…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 4. Our fourth and final daily wrap-up features highlights from the key late breaking trials,…
